Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 11201-11250 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04471779
Information About Alzheimer's Disease for Latinos in New York City
NA
Active, not recruiting
374 participants
Started: Aug 13, 2021 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT04849871
Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma
NA
Active, not recruiting
134 participants
Started: Aug 12, 2021 · Completed: Aug 6, 2029
4 conditions
2 sponsors
1 location
NCT04946734
Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine
PHASE3
Active, not recruiting
440 participants
Started: Aug 12, 2021 · Completed: Sep 6, 2025
2 conditions
1 sponsor
21 locations
NCT04929678
Study of the Braive Growth Modulation System for Progressive Pediatric Scoliosis
NA
Active, not recruiting
10 participants
Started: Aug 12, 2021 · Completed: Dec 25, 2029
2 conditions
2 sponsors
4 locations
NCT04717050
Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity
NA
Active, not recruiting
160 participants
Started: Aug 12, 2021 · Completed: Jun 15, 2026
4 conditions
2 sponsors
1 location
NCT04959448
Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
N/A
Active, not recruiting
717 participants
Started: Aug 12, 2021 · Completed: Mar 25, 2027
1 condition
2 sponsors
81 locations
NCT04674683
Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma
PHASE3
Active, not recruiting
450 participants
Started: Aug 12, 2021 · Completed: Dec 31, 2026
2 conditions
2 sponsors
139 locations
NCT05112432
EPI-MINN: Targeting Cognition and Motivation
NA
Active, not recruiting
400 participants
Started: Aug 12, 2021 · Completed: Jun 30, 2026
1 condition
2 sponsors
3 locations
NCT05077098
Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer
PHASE1
Active, not recruiting
8 participants
Started: Aug 12, 2021 · Completed: Jul 31, 2028
1 condition
1 sponsor
1 location
NCT05007938
Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer
PHASE2
Active, not recruiting
30 participants
Started: Aug 12, 2021 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT05867576
Acceptance and Commitment Therapy in Tuberous Sclerosis Complex
NA
Active, not recruiting
15 participants
Started: Aug 12, 2021 · Completed: Mar 30, 2024
1 condition
3 sponsors
1 location
NCT04710563
SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs
N/A
Active, not recruiting
458 participants
Started: Aug 11, 2021 · Completed: Sep 30, 2028
1 condition
14 sponsors
1 location
NCT04663997
177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer
PHASE2
Active, not recruiting
200 participants
Started: Aug 11, 2021 · Completed: Dec 31, 2026
1 condition
3 sponsors
10 locations
NCT05018000
Cancer Financial Experience
NA
Active, not recruiting
371 participants
Started: Aug 11, 2021 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT04923906
Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR Mutations
PHASE3
Active, not recruiting
624 participants
Started: Aug 11, 2021 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT05072288
A Remote Physical Activity Program in the Population Suffering from Type 1 Myotonic Dystrophy
NA
Active, not recruiting
40 participants
Started: Aug 11, 2021 · Completed: Dec 1, 2026
1 condition
1 sponsor
2 locations
NCT05307562
Efficacy of Respiratory Rehabilitation After COVID-19 Severe Infection
NA
Active, not recruiting
24 participants
Started: Aug 10, 2021 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT04439968
Neonatal Brain Oxygenation Study
NA
Active, not recruiting
100 participants
Started: Aug 10, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04830228
BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions
N/A
Active, not recruiting
160 participants
Started: Aug 10, 2021 · Completed: Feb 28, 2028
1 condition
1 sponsor
15 locations
NCT04964115
Post Acute Sequelae of COVID-19
N/A
Active, not recruiting
500 participants
Started: Aug 10, 2021 · Completed: May 31, 2027
5 conditions
1 sponsor
1 location
NCT06025539
Animal-assisted Resilience Training for Children With Stressful Life Events or Autism Spectrum Disorder
NA
Active, not recruiting
83 participants
Started: Aug 10, 2021 · Completed: Oct 31, 2025
2 conditions
1 sponsor
1 location
NCT05055843
Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer
NA
Active, not recruiting
33 participants
Started: Aug 10, 2021 · Completed: Jan 31, 2027
2 conditions
1 sponsor
1 location
NCT04780217
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
PHASE1/PHASE2
Active, not recruiting
42 participants
Started: Aug 10, 2021 · Completed: Aug 31, 2025
6 conditions
1 sponsor
6 locations
NCT05000788
Neurophysiological RCT of Qigong in Elderly With Depression
NA
Active, not recruiting
60 participants
Started: Aug 9, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT04345718
EXHIT ENTRE Comparative Effectiveness Trial
PHASE2/PHASE3
Active, not recruiting
344 participants
Started: Aug 9, 2021 · Completed: Oct 31, 2025
3 conditions
3 sponsors
6 locations
NCT04787991
Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
PHASE1
Active, not recruiting
45 participants
Started: Aug 9, 2021 · Completed: Jan 11, 2025
1 condition
4 sponsors
6 locations
NCT04848272
Inhibition of Plasma Kallikrein as a New Therapy for Lung Injury
PHASE1
Active, not recruiting
48 participants
Started: Aug 9, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05013307
Clinical Assessment of Sports Exertion
NA
Active, not recruiting
125 participants
Started: Aug 7, 2021 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT04643379
Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
PHASE2
Active, not recruiting
30 participants
Started: Aug 7, 2021 · Completed: Oct 31, 2028
2 conditions
3 sponsors
1 location
NCT06525246
Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer
PHASE1
Active, not recruiting
78 participants
Started: Aug 6, 2021 · Completed: Apr 30, 2026
5 conditions
1 sponsor
13 locations
NCT04852783
US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair
PHASE4
Active, not recruiting
250 participants
Started: Aug 6, 2021 · Completed: Dec 31, 2029
1 condition
1 sponsor
20 locations
NCT04899661
A Study to Learn More About the Long-term Safety and Effectiveness of Molidustat as a Treatment for Japanese Men and Women With Renal Anemia
N/A
Active, not recruiting
1,081 participants
Started: Aug 6, 2021 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT04918459
EUS Glue vs Endoscopic Variceal Band Ligation for Prevention of Rebleeding in Patients With HCC and EV Bleeding: a Retrospective Comparative Study
N/A
Active, not recruiting
70 participants
Started: Aug 6, 2021 · Completed: Dec 30, 2026
4 conditions
1 sponsor
1 location
NCT05003817
Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventricular Unloading
PHASE3
Active, not recruiting
300 participants
Started: Aug 6, 2021 · Completed: Jun 30, 2026
2 conditions
23 sponsors
1 location
NCT04958252
A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated
PHASE1
Active, not recruiting
56 participants
Started: Aug 5, 2021 · Completed: Oct 24, 2023
1 condition
1 sponsor
1 location
NCT04973384
Ocular Comorbidity in Atopic Dermatitis
N/A
Active, not recruiting
120 participants
Started: Aug 5, 2021 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT04955730
NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies
PHASE2/PHASE3
Active, not recruiting
300 participants
Started: Aug 5, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05050591
Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent
NA
Active, not recruiting
20 participants
Started: Aug 5, 2021 · Completed: Jul 31, 2025
1 condition
3 sponsors
2 locations
NCT04960709
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin
PHASE3
Active, not recruiting
712 participants
Started: Aug 5, 2021 · Completed: Sep 8, 2028
1 condition
1 sponsor
202 locations
NCT04940611
A Study of Surgical Interventions in Fistulizing Conditions
N/A
Active, not recruiting
750 participants
Started: Aug 5, 2021 · Completed: May 2, 2026
5 conditions
1 sponsor
41 locations
NCT04945746
Dispersion Stability
NA
Active, not recruiting
35 participants
Started: Aug 5, 2021 · Completed: Jan 28, 2025
1 condition
1 sponsor
1 location
NCT04558398
Impact of Exercise on Mitochondria in Cancer Patients.
NA
Active, not recruiting
15 participants
Started: Aug 5, 2021 · Completed: Mar 30, 2024
2 conditions
1 sponsor
1 location
NCT04733118
Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer
PHASE2
Active, not recruiting
393 participants
Started: Aug 5, 2021 · Completed: Mar 31, 2028
1 condition
2 sponsors
41 locations
NCT04967807
Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)
NA
Active, not recruiting
57 participants
Started: Aug 5, 2021 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT04341701
Phenotype Identification Based on Multimodal MRI Analysis of Patients With Bronchial Obstructive Diseases
NA
Active, not recruiting
100 participants
Started: Aug 5, 2021 · Completed: Mar 30, 2024
1 condition
1 sponsor
6 locations
NCT04956692
Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)
PHASE3
Active, not recruiting
531 participants
Started: Aug 5, 2021 · Completed: Oct 14, 2026
1 condition
1 sponsor
126 locations
NCT04713514
OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC
PHASE2
Active, not recruiting
180 participants
Started: Aug 5, 2021 · Completed: Dec 31, 2025
2 conditions
3 sponsors
40 locations
NCT05484453
Validation of the GoCheck Kids® Eye Screeningtest in Infants in Flanders
N/A
Active, not recruiting
460 participants
Started: Aug 4, 2021 · Completed: May 31, 2025
2 conditions
1 sponsor
1 location
NCT04972851
AIRB-4: Self-Determined Learning Model of Instruction
NA
Active, not recruiting
358 participants
Started: Aug 4, 2021 · Completed: Dec 1, 2025
2 conditions
7 sponsors
3 locations
NCT04791839
Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer
PHASE2
Active, not recruiting
30 participants
Started: Aug 4, 2021 · Completed: Dec 31, 2029
3 conditions
2 sponsors
1 location
Previous
1
More pages
222
223
224
225
226
227
228
More pages
431
Next